BRSL vs CALY

The Advanced Deterministic Scorecard reveals critical weaknesses: a Piotroski F-Score of just 2/9 indicates severe financial distress, and the absence of an Altman Z-Score prevents safety confirmation. Despite high earnings growth and a bullish analyst recommendation, the stock trades at a massive premium to both Graham ($3.05) and intrinsic value ($2.65), with deteriorating earnings surprises, alarming leverage (Debt/Equity: 3.18), and a dangerously high payout ratio (888.89%). Technical trend is deeply bearish, and recent price performance shows consistent downward momentum, reinforcing structural concerns.

CALY exhibits a severe disconnect between its current market price ($15.31) and its deterministic value, with a Piotroski F-Score of 4/9 indicating only marginal stability. The stock trades at a massive premium to its Graham Number ($7.29) and Intrinsic Value ($1.47), while facing catastrophic revenue declines (-60.20% YoY). Despite a strong 1-year price rally, the underlying fundamentals—specifically negative profit margins and a critical liquidity shortage (Quick Ratio 0.24)—suggest the current valuation is speculative rather than fundamental.